Doctor's Bio
A board-certified surgeon, Dr. Seth J. Concors, MD, specializes in gastrointestinal surgical oncology. His clinical practice centers on the surgical management of neuroendocrine tumors, hepatobiliary and peritoneal surface malignancies, including cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Dr. Concors is an assistant professor of surgery in the Division of Surgical Oncology at the Emory University School of Medicine. He serves as associate program director of the Complex General Surgical Oncology Fellowship and the General Surgery Residency. He is also director of the Surgical Oncology Research Fellowship.
His research includes studies aimed at improving outcomes and quality of life for patients undergoing complex oncologic surgery. He has served as lead investigator for clinical trials and is committed to improving clinical outcomes in neuroendocrine tumors and peritoneal surface malignancies. His research interests include clinical trials, health services and quality improvement.
Dr. Concors has authored numerous peer-reviewed publications, book chapters and consensus guidelines in surgical oncology. He is an active reviewer for several high-impact journals, including Annals of Surgical Oncology, Annals of Surgery and The Oncologist.
Board Certifications
American Board of Surgery
Affiliations
Emory
Education & Training
- Medical School: New York University Grossman School of Medicine
- Residency: University of Pennsylvania Department of Surgery
Fellowships
MD Anderson Cancer Center Surgical Oncology
Locations and Directions
Grady Memorial Hospital
Phone: (404) 616-1000
Location:
80 Jesse Hill Jr Drive SE
Atlanta, GA 30303
Publications
- ASO Visual Abstract: Secondary Cytoreductive Surgery ± Hyperthermic Intraperitoneal Chemotherapy for Recurrent Colorectal Cancer Peritoneal Metastases.
Oppat KM, Bennett FJ, Patel SH, Raoof M, Baumgartner JM, Mogal HD, Lambert LA, Abbott DE, Greer JB, Grotz TE, Fournier KF, Dineen SP, Powers B, Zaidi MY, Winer JH, Russell MC, Staley CA, Cloyd JM, Maithel SK, Concors SJ
Annals of surgical oncology. 2026;
PMID: 42606654 - Secondary Cytoreductive Surgery ± Hyperthermic Intraperitoneal Chemotherapy for Recurrent Colorectal Cancer Peritoneal Metastases.
Oppat KM, Bennett FJ, Patel SH, Raoof M, Baumgartner JM, Mogal HD, Lambert LA, Abbott DE, Greer JB, Grotz TE, Fournier KF, Dineen SP, Powers B, Zaidi MY, Winer JH, Russell MC, Staley CA, Cloyd JM, Maithel SK, Concors SJ
Annals of surgical oncology. 2026;
PMID: 42547752 - Grade progression and high-grade transformation in neuroendocrine neoplasms.
Grewal US, Gosse M, Concors SJ, Gonzalez RS, Ear PH, Halperin DM, Chandrasekharan C, Singh S, Bellizzi AM
Endocrine-related cancer. 2026;
PMID: 42439380 - Robust response to pembrolizumab in temozolomide-associated hypermutated and microsatellite instability-high functional pancreatic neuroendocrine tumor.
Grewal US, Shi CW, Muzahir S, Ear PH, Concors SJ, Halperin DM
The oncologist. 2026;
PMID: 42296390 - Germline genetic testing among patients with pancreatic adenocarcinoma: A Pancreatic Cancer Action Network patient survey.
Grewal US, Patel RR, Loeffler BT, Rathjens S, Abdilleh K, Zelada-Arenas F, Hornstein NJ, Brown TJ, Concors SJ, Fei NH, Sharif S, Chandrasekharan C
Cancer. 2026;132(10):e70446.
PMID: 42118569 - Optimal duration of neoadjuvant chemotherapy prior to CRS ± HIPEC for colorectal cancer: An assessment of survival and postoperative outcomes.
Bennett FJ, Oppat KM, Zaidi MY, Winer J, Russell MC, Staley C, Maithel SK, Concors SJ
Surgical oncology insight. 2026;
PMID: 42039684 - Consensus Guideline for the Management of Peritoneal Metastases from Neuroendocrine Neoplasms.
Su DG, Brown LM, Bansal VV, Bakkila B, Concors SJ, Turaga KK, Gunderson C, Bergsland E, Strosberg JR, Halfdanarson TR, Metz DC, Kunstman JW, Kunz PL, Gangi A,
Annals of surgical oncology. 2026;33(6):5204-5221.
PMID: 40560496 - Consensus guideline for the management of peritoneal metastases from neuroendocrine neoplasms.
Su DG, Brown LM, Bansal VV, Bakkila B, Concors SJ, Turaga KK, Gunderson C, Bergsland E, Strosberg JR, Halfdanarson TR, Metz DC, Kunstman JW, Kunz PL, Gangi A,
Cancer. 2025;131(13):e35871.
PMID: 40558053 - Differential Effects of HDAC6 Inhibition Versus Knockout During Hepatic Ischemia-Reperfusion Injury Highlight Importance of HDAC6 C-terminal Zinc-finger Ubiquitin-binding Domain.
Concors SJ, Hernandez PT, O'Brien C, DePaolo J, Murken DR, Aufhauser DD, Wang Z, Xiong Y, Krumeich L, Ge G, Beier UH, Bhatti TR, Kozikowski AP, Avelar LAA, Kurz T, Hancock WW, Levine MH
Transplantation. 2024;108(10):2084-2092.
PMID: 38685198 - Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Benefit.
Bhutiani N, Grotz TE, Concors SJ, White MG, Helmink BA, Raghav KP, Taggart MW, Beaty KA, Royal RE, Overman MJ, Matamoros A, Scally CP, Rafeeq S, Mansfield PF, Fournier KF
Annals of surgical oncology. 2024;31(1):614-621.
PMID: 37872456
PLANNING
PREPARING FOR YOUR VISIT
Whether you’re a patient or you’re visiting one, a little planning beforehand can make your visit to Grady easier and more comfortable. Here, you’ll find everything you need to prepare for your visit, including an appointment checklist, admissions information, dining options, and much more.